Aims: Develop and validate new non-contrast computed tomography (NCCT) score to predict hematoma expansion (HE) in spontaneous intracerebral hemorrhage (SICH) patients based on hematoma's shape irregularity and density heterogeneity.
Materials And Methods: Retrospective study was conducted among 136 patients for development and 90 patients for validation at two separate hospitals. SICH patients with NCCT scanned within 6 hours of symptoms and follow-up NCCT scanned within 24 hours were enrolled. Black hole sign and blend sign were integrated as combined heterogeneity; likewise, satellite sign and island sign were integrated as combined irregularity. Binary logistic regression analysis screened the covariates associated with HE. Nomogram was generated using the predicted value of binary logistic regression model to derive NCCT score to predict HE.
Results: A total of 65 patients had HE in developmental cohort, where history of hypertension [odds ratio (OR) 2.56; 95% CI 1.169-5.607; P=0.019], initial NCCT time ≤ 3 hours (OR 2.50; 95% CI 1.169-5.327; P=0.018), combined heterogeneity (OR 2.50; 95% CI 1.160-5.365; P=0.019), and combined irregularity (OR 2.63; 95% CI 1.164-5.942; P=0.020) were independently associated with HE. A score was derived and a single point was allocated to each independently associated variable. HE was observed in 35 patients in validation cohort, which showed a proportional increase in the probability of HE with an increase in score accumulated.
Conclusion: New four-point NCCT score to predict HE was developed and validated, which may be regarded as fair predictive score where advance facilities are rarely available.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.crad.2024.08.035 | DOI Listing |
Crohns Colitis 360
January 2025
Department of Gastroenterology and Liver Services, Concord Repatriation General Hospital, Sydney, New South Wales, Australia.
Background And Aims: Vedolizumab is s gut-selective advanced therapy that is safe and efficacious for the treatment of ulcerative colitis (UC). Once patients achieve successful induction, there is a risk of loss of response leading to eventual flare. We aimed to identify these predictive factors and develop a practical scoring system to determine the ongoing efficacy of vedolizumab.
View Article and Find Full Text PDFAm Heart J Plus
January 2025
The University of Notre Dame Australia, Fremantle, WA, Australia.
Background: There is limited data showing the predictive accuracy of traditional cardiovascular risk scores (CVRS) to predict asymptomatic coronary artery disease (CAD) determined by coronary computed tomography angiography (CCTA).
Methods: Asymptomatic individuals without known CAD undergoing a screening CCTA and sufficient data to calculate their CVRS, were extracted retrospectively. Atherosclerosis was extracted using natural language processing of the CCTA report, including the coronary artery calcium score (CACS) and the extent and severity of CAD.
Biochem Biophys Rep
March 2025
Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital of Kunming Medical University, No.374 Yunnan-Burma Road, Kunming, Yunnan, 650101, China.
Background: Hepatocellular carcinoma (HCC) is a globally prevalent disease. Our article evaluates risk models based on autophagy- and HCC-related genes and their prognostic value by bioinformatics analytical methods to provide a scientific basis for clinical treatment.
Methods: Prognostic genes were identified by univariate and multivariate Cox analyses, and risk scores were calculated.
Ann Gastroenterol Surg
January 2025
Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan.
Aims: Liver fibrosis predisposes patients to liver failure and hepatocellular carcinoma. Various markers, which can be calculated easily from serum parameters, have been reported to predict liver fibrosis accurately. This study investigated the prognostic factors, including blood-based markers for liver fibrosis of patients with hepatocellular carcinoma following initial curative hepatectomy.
View Article and Find Full Text PDFAnn Gastroenterol Surg
January 2025
Division of Gastroenterological, Hepato-Biliary-Pancreatic, Transplantation and Pediatric Surgery, Department of Surgery Shinshu University School of Medicine Matsumoto Japan.
Background And Aim: Post-hepatectomy liver failure (PHLF) after major hepatopancreatoduodenectomy (HPD) is a challenge to overcome. However, the appropriate target proportion of the future liver remnant (pFLR) to prevent severe PHLF in major HPD remains uncertain. This study aimed to determine the minimum pFLR required for safe major HPD.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!